Navigation Links
Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

WHITE PLAINS, N.Y., Jan. 13 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has awarded a $550,000 grant to Anthony Letai, M.D., Ph.D., Department of Medical Oncology at Dana-Farber Cancer Institute in Boston. Millennium: The Takeda Oncology Company of Cambridge, MA provided support to the LLS Career Development Scholar program, which will be used to fund a portion of the five-year research project.

The LLS Scholar in Clinical Research Career Development grant will support Dr. Letai's work on apoptosis, the normal process for eliminating old, unneeded or unhealthy cells. In cancer, this process often is disrupted. Dr. Letai's study, Detecting and Targeting Blocks in Apoptosis in Hematologic Malignancies, is designed to identify the molecules that allow cancer cells to proliferate by inhibiting apoptosis in patients with chronic lymphocytic leukemia, acute lymphoblastic leukemia and diffuse large B-cell lymphoma. His lab has been testing novel targeted therapies that attack these molecules and selectively kill cancer cells.

"I am absolutely delighted to be an LLS Scholar and I appreciate Millennium's support of this important scholarship program," said Dr. Letai. "This grant allows me to be a little more aggressive and take a few more risks that might not otherwise be possible."

LLS's Career Development Program funds talented investigators at different points in their careers: Fellows and Special Fellows during their post-doctoral training years; and Scholars and Scholars in Clinical Research early in their independent academic positions. The program recruits and supports young scientists in blood cancer research, helping populate the field with the best and brightest young researchers who are accomplishing cutting-edge research in established and new laboratories.

"Dr. Letai was selected for this grant because his lab has been applying state-of-the-art scientific techniques and sound scientific principles, and his work has shown great promise in leading to improved treatments for patients with leukemia and lymphoma," said Barton Kamen, M.D., Ph.D., LLS's chief medical officer.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

    Contact: Andrea Greif
    (914) 821-8958

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
2. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
3. UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes
4. Penn researchers unlock molecular origin of blood stem cells
5. McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine
6. Researcher wins $1.2 million grant for gene regulation work
7. McGill researchers discover gene that increases susceptibility to Crohns disease
8. Researchers Gain Insights Into Aging in Mice
9. Researchers discover target that could ease spinal muscular atrophy symptoms
10. Health-monitoring technology helps seniors live at home longer, MU researchers find
11. Old gastrointestinal drug slows aging, McGill researchers say
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
Breaking Medicine Technology: